{"date":"2026-03-13","count":72,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-8403-2026-03-13-2130-1howjn","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"21:30:30","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-03-13 21:30，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-13-2043-11bivm1","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:43:44","subject":"公告本公司國內第五次無擔保轉換公司債轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-13 20:43，「公告本公司國內第五次無擔保轉換公司債轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-13-2042-lg2a0e","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:42:41","subject":"公告董事會決議召開115年度股東常會暨受理股東提案等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-13 20:42，「公告董事會決議召開115年度股東常會暨受理股東提案等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-13-2039-1i19rvk","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:39:09","subject":"公告本公司董事會決議普通股股利分派發放現金","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-13 20:39，「公告本公司董事會決議普通股股利分派發放現金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-13-2035-5j9yh6","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:35:52","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-13 20:35，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-13-2034-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:34:55","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-13 20:34，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-13-2024-ddrcnh","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"20:24:03","subject":"公告本公司經理人異動。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-13 20:24，「公告本公司經理人異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-13-2021-1c7j5p9","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"20:21:42","subject":"公告本公司經主管機關核准延長115年度第一次現金增資發行新股案之特定人繳款期間相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-13 20:21，「公告本公司經主管機關核准延長115年度第一次現金增資發行新股案之特定人繳款期間相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-13-1925-1jdpc1v","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"19:25:14","subject":"本公司董事會決議補充召開115年股東常會公告（受理董事及獨立董事提名相關事宜）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-13 19:25，「本公司董事會決議補充召開115年股東常會公告（受理董事及獨立董事提名相關事宜）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-13-1922-stgbfl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"19:22:06","subject":"公告本公司董事會決議不擬分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-13 19:22，「公告本公司董事會決議不擬分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-13-1919-15l51d8","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"19:19:20","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-13 19:19，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-13-1919-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"19:19:03","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-13 19:19，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-13-1918-5j9yh6","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"19:18:36","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-13 19:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-03-13-1844-h3ryi2","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"18:44:01","subject":"公告本公司董事會決議辦理初次創新版上市掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-03-13 18:44，「公告本公司董事會決議辦理初次創新版上市掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-03-13-1843-11b1948","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"18:43:49","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-03-13 18:43，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-03-13-1843-2iz4hx","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"18:43:22","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-03-13 18:43，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-03-13-1841-5j9yh6","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"18:41:48","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-03-13 18:41，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-13-1823-ngnrqw","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"18:23:23","subject":"衛福部核准麗晶診所與本公司合作之「自體脂肪幹細胞治療皮下及軟組織缺損」細胞治療技術施行計畫","clause":"第53款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-13 18:23，「衛福部核准麗晶診所與本公司合作之「自體脂肪幹細胞治療皮下及軟組織缺損」細胞治療技術施行計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-03-13-1803-x599kd","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"18:03:48","subject":"本公司董事會決議不發放114年度股利","clause":"第14款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-03-13 18:03，「本公司董事會決議不發放114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-03-13-1759-e6hr0k","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:59:23","subject":"公告本公司董事會通過114年度合併財務報表","clause":"第31款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-03-13 17:59，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-03-13-1758-1howjn","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:58:04","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-03-13 17:58，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-13-1754-ch5vso","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:54:51","subject":"公告本公司董事會決議召開115年股東常會事宜(增列召集事宜)-配合電子投票系統，刪除增列字樣。","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-13 17:54，「公告本公司董事會決議召開115年股東常會事宜(增列召集事宜)-配合電子投票系統，刪除增列字樣。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1750-3qapee","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:50:44","subject":"公告本公司資訊安全主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:50，「公告本公司資訊安全主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1750-1jhewlf","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:50:23","subject":"公告本公司公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:50，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1750-1qj44hg","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:50:01","subject":"公告本公司財務主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:50，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1749-1vhu1xi","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:49:26","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:49，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1748-58zfmu","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:48:56","subject":"公告本公司總經理異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:48，「公告本公司總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1748-17wo67m","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:48:32","subject":"公告本公司副董事長異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:48，「公告本公司副董事長異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1748-17snutz","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:48:00","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:48，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1747-6qjcx1","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:47:35","subject":"公告本公司董事會決議114年第4季股利發放","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:47，「公告本公司董事會決議114年第4季股利發放」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-13-1747-vsk5u","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"17:47:18","subject":"公告本公司董事會通過民國114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-13 17:47，「公告本公司董事會通過民國114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-03-13-1737-11wjw0o","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"17:37:45","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-03-13 17:37，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-13-1709-16ykuak","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"17:09:25","subject":"公告本公司TAH3311取得韓國「ApixabanFilm Product and Uses Thereof」發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-13 17:09，「公告本公司TAH3311取得韓國「ApixabanFilm Product and Uses Thereof」發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-13-1702-12dcqaz","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"17:02:47","subject":"公告本公司法人董事中租實業股份有限公司基於其內部營運規劃考量辭任","clause":"第6款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-13 17:02，「公告本公司法人董事中租實業股份有限公司基於其內部營運規劃考量辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-03-13-1659-1lfp08x","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:59:38","subject":"公告本公司114年度合併財務報告業經提報董事會通過","clause":"第31款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-03-13 16:59，「公告本公司114年度合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1643-1eymgti","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:43:21","subject":"公告本公司審計委員及薪酬委員辭職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 16:43，「公告本公司審計委員及薪酬委員辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1642-1kl0ndz","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:42:59","subject":"公告本公司獨立董事辭任暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 16:42，「公告本公司獨立董事辭任暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1642-nj2gbg","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:42:33","subject":"公告本公司執行長及發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 16:42，「公告本公司執行長及發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1641-54swv6","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:41:36","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 16:41，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1641-1g6i233","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:41:05","subject":"公告本公司董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 16:41，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-03-13-1637-z3kg5a","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"16:37:30","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分派","clause":"第51款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-03-13 16:37，「公告本公司董事會通過114年度員工酬勞及董事酬勞分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-03-13-1636-uj6bsw","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:36:58","subject":"攝護腺微創治療醫材Urocross成功取得美國FDA上市許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-03-13 16:36，「攝護腺微創治療醫材Urocross成功取得美國FDA上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-03-13-1621-sn40ae","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:21:49","subject":"公告本公司資安主管異動","clause":"第8款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-03-13 16:21，「公告本公司資安主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-13-1621-1ctgck9","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:21:10","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-13 16:21，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-03-13-1621-1vhu1xi","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:21:01","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-03-13 16:21，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-03-13-1608-q1evj9","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"16:08:54","subject":"公告台灣神隆股份有限公司舉行2025全年法人說明會","clause":"第12款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-03-13 16:08，「公告台灣神隆股份有限公司舉行2025全年法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-13-1601-1v89vf8","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"16:01:46","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-13 16:01，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-13-1553-9zluly","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:53:21","subject":"本公司董事會決議通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-13 15:53，「本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1553-1o3ubk4","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:53:16","subject":"本公司董事會通過114年度股利分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:53，「本公司董事會通過114年度股利分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-13-1548-1421rlj","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:48:12","subject":"本公司晉升Scott Johnson為品保管理執行處長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-13 15:48，「本公司晉升Scott Johnson為品保管理執行處長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1546-pri9i8","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:46:06","subject":"召開本公司115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:46，「召開本公司115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-03-13-1531-1amee0w","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:31:27","subject":"公告本公司受邀參加德信證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-03-13 15:31，「公告本公司受邀參加德信證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-03-13-1528-6hf3cj","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"15:28:26","subject":"依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之規定辦理公告","clause":"第23款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-03-13 15:28，「依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-03-13-1526-1cccuo4","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:26:18","subject":"公告本公司董事長訂定除息基準日","clause":"第14款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-03-13 15:26，「公告本公司董事長訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1524-1s6c2we","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:24:15","subject":"本公司董事會通過114年度員工及董事酬勞分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:24，「本公司董事會通過114年度員工及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1522-m2xc3g","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:22:44","subject":"公告本公司不繼續辦理114年度股東會決議通過之私募普通股增資案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:22，「公告本公司不繼續辦理114年度股東會決議通過之私募普通股增資案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1521-6wcds","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:21:55","subject":"本公司董事會決議以私募現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:21，「本公司董事會決議以私募現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-13-1521-z7wl9","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:21:36","subject":"本公司114年度合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-13 15:21，「本公司114年度合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-13-1517-gx3rxo","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:17:23","subject":"(更正)公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-13 15:17，「(更正)公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-13-1514-7lvi8z","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"15:14:30","subject":"本公司會計主管異動","clause":"第8款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-13 15:14，「本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-13-1509-15d3bmy","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"15:09:24","subject":"更新115/3/12公告本公司董事會決議通過一一五年股東常會新增召集事由","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-13 15:09，「更新115/3/12公告本公司董事會決議通過一一五年股東常會新增召集事由」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-03-13-1501-1h7plh0","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"15:01:25","subject":"公告本公司董事會通過114年合併財務報告","clause":"第31款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-03-13 15:01，「公告本公司董事會通過114年合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-13-1447-1vuvt37","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"14:47:52","subject":"代子公司Chemix Inc.公告現金股利配發基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-13 14:47，「代子公司Chemix Inc.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-13-1447-2a419k","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"14:47:39","subject":"代子公司Chemix Inc.公告董事會決議股利分配","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-13 14:47，「代子公司Chemix Inc.公告董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-13-1447-vz7f9l","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"14:47:26","subject":"代子公司Chemix Inc.公告股東會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-13 14:47，「代子公司Chemix Inc.公告股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-13-1444-1167ixk","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-13","time":"14:44:12","subject":"本公司受邀參加Jefferies舉辦之Jefferies Asia Forum","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-13 14:44，「本公司受邀參加Jefferies舉辦之Jefferies Asia Forum」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-03-13-1208-1m2w1fj","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"12:08:49","subject":"代子公司Elixiron Immunotherapeutics (Hong Kong)limited 公告授權方Pilatus Biosciences Inc.抗體PLT012於腫瘤之第一期臨床試驗完成首例病患給藥。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-03-13 12:08，「代子公司Elixiron Immunotherapeutics (Hong Kong)limited 公告授權方Pila」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-03-13-0653-1z0mdky","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-03-13","time":"06:53:22","subject":"公告本公司董事會決議召開115年股東常會開會相關事宜","clause":"第32款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-03-13 06:53，「公告本公司董事會決議召開115年股東常會開會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-13-0623-1govtng","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"06:23:18","subject":"公告本公司獨立董事對薪酬委員會、審計委員會及董事會決議事項表示反對意見。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-13 06:23，「公告本公司獨立董事對薪酬委員會、審計委員會及董事會決議事項表示反對意見。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-13-0614-1s60zse","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"06:14:04","subject":"公告本公司董事會決議股利分派。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-13 06:14，「公告本公司董事會決議股利分派。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-13-0610-11b1948","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"06:10:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-13 06:10，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-13-0606-d7ntug","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-13","time":"06:06:41","subject":"公告本公司董事會通過114年度合併財務報告。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-13 06:06，「公告本公司董事會通過114年度合併財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}